CN Stock MarketDetailed Quotes
600062 China Resources Double-Crane Pharmaceutical
- 20.55
- -0.46-2.19%
Market Closed Dec 13 15:00 CST
21.36BMarket Cap15.84P/E (TTM)
20.94High20.50Low109.32KlotVolume20.94Open21.01Pre Close225.95MTurnover1.06%Turnover Ratio16.02P/E (Static)1.04BShares26.0552wk High2.10P/B21.11BFloat Cap15.5852wk Low23.11Limit Up1.03BShs Float36.03Historical High18.91Limit Down2.09%Amplitude-1.85Historical Low0.36Dividend TTM20.67Avg Price65.39KlotAsk1.74%Div YieldTTM100Lot Size41.81KlotBid
China Resources Double-Crane Pharmaceutical Key Stats
EPS
According to the latest financial report of China Resources Double-Crane Pharmaceutical, the latest earnings per share (TTM) for the company is 1.36. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out China Resources Double-Crane Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 9.81.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of China Resources Double-Crane Pharmaceutical shows that the company's current ratio is 1.59, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of China Resources Double-Crane Pharmaceutical, the quick ratio is 1.26, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of China Resources Double-Crane Pharmaceutical? The latest ROE figure is 12.47%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of China Resources Double-Crane Pharmaceutical, the total asset return on investment (ROA) is 8.83%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check China Resources Double-Crane Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 58.46%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of China Resources Double-Crane Pharmaceutical, the net profit margin is 16.52%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
